Last reviewed · How we verify
A Randomized, Parallel, Double-blind, Multi-center, Comparative Study to Exploratively Evaluate the Efficacy and Safety of Cosalin® Monotherapy vs. Cosalin® and Xarlin® Combination Therapy in Patients With Allergic Rhinitis
Title of Study: A randomized, parallel, double-blind, multi-center, comparative study to evaluate the efficacy and safety of Cosalin monotherapy versus Cosalin and Xarlin combination therapy in patients with allergic rhinitis Objective of study: To exploratively evaluate superiority of combination therapy - twice-daily Cosalin Tab (Petasites hybridus CO2 extract) with once-daily Xarlin Tab (Levocetirizine HCl) - compared to monotherapy of Cosalin with allergic rhinitis subjects.
Details
| Lead sponsor | HK inno.N Corporation |
|---|---|
| Phase | Phase 4 |
| Status | UNKNOWN |
| Enrolment | 100 |
| Start date | 2009-10 |
Conditions
- Perennial Allergic Rhinitis
Interventions
- Xarlin (Levocetirizine)
- Cosalin (Petasites hybridus CO2 extract)
Primary outcomes
- Compare efficacy improvement of combination therapy group and mono therapy group by percent change of 4 TSS from baseline to end of treatment by investigator. — 2 weeks